Verapamil for severe hyperkinetic movement disorders
Identifieur interne : 004E71 ( Main/Exploration ); précédent : 004E70; suivant : 004E72Verapamil for severe hyperkinetic movement disorders
Auteurs : Ovsiew [États-Unis] ; Kimford J. Meador [États-Unis] ; Kapil Sethi [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1998-03.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Calcium Channel Blockers, Verapamil.
- drug effects : Neurologic Examination.
- drug therapy : Hyperkinesis.
- Adult, Humans, Male.
Abstract
The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.
Url:
DOI: 10.1002/mds.870130224
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003723
- to stream Istex, to step Curation: 003723
- to stream Istex, to step Checkpoint: 003606
- to stream PubMed, to step Corpus: 004461
- to stream PubMed, to step Curation: 004461
- to stream PubMed, to step Checkpoint: 004301
- to stream Ncbi, to step Merge: 004F23
- to stream Ncbi, to step Curation: 004F23
- to stream Ncbi, to step Checkpoint: 004F23
- to stream Main, to step Merge: 007D83
- to stream Main, to step Curation: 004E71
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Verapamil for severe hyperkinetic movement disorders</title><author><name sortKey="Ovsiew" sort="Ovsiew" uniqKey="Ovsiew" last="Ovsiew">Ovsiew</name></author><author><name sortKey="Meador, Kimford J" sort="Meador, Kimford J" uniqKey="Meador K" first="Kimford J." last="Meador">Kimford J. Meador</name></author><author><name sortKey="Sethi, Kapil" sort="Sethi, Kapil" uniqKey="Sethi K" first="Kapil" last="Sethi">Kapil Sethi</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B88428F68E77C9AFF77EACBE81F511A9F5D99294</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1002/mds.870130224</idno><idno type="url">https://api.istex.fr/document/B88428F68E77C9AFF77EACBE81F511A9F5D99294/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003723</idno><idno type="wicri:Area/Istex/Curation">003723</idno><idno type="wicri:Area/Istex/Checkpoint">003606</idno><idno type="wicri:doubleKey">0885-3185:1998:Ovsiew:verapamil:for:severe</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:9539352</idno><idno type="wicri:Area/PubMed/Corpus">004461</idno><idno type="wicri:Area/PubMed/Curation">004461</idno><idno type="wicri:Area/PubMed/Checkpoint">004301</idno><idno type="wicri:Area/Ncbi/Merge">004F23</idno><idno type="wicri:Area/Ncbi/Curation">004F23</idno><idno type="wicri:Area/Ncbi/Checkpoint">004F23</idno><idno type="wicri:doubleKey">0885-3185:1998:Ovsiew F:verapamil:for:severe</idno><idno type="wicri:Area/Main/Merge">007D83</idno><idno type="wicri:Area/Main/Curation">004E71</idno><idno type="wicri:Area/Main/Exploration">004E71</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Verapamil for severe hyperkinetic movement disorders</title><author><name sortKey="Ovsiew" sort="Ovsiew" uniqKey="Ovsiew" last="Ovsiew">Ovsiew</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Illinois</region></placeName><wicri:cityArea>University of Chicago, Chicago</wicri:cityArea></affiliation></author><author><name sortKey="Meador, Kimford J" sort="Meador, Kimford J" uniqKey="Meador K" first="Kimford J." last="Meador">Kimford J. Meador</name><affiliation wicri:level="2"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Medical College of Georgia, Augusta, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Sethi, Kapil" sort="Sethi, Kapil" uniqKey="Sethi K" first="Kapil" last="Sethi">Kapil Sethi</name><affiliation wicri:level="2"><country xml:lang="fr" wicri:curation="lc">États-Unis</country><wicri:regionArea>Medical College of Georgia, Augusta, Georgia</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1998-03">1998-03</date><biblScope unit="vol">13</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="341">341</biblScope><biblScope unit="page" to="344">344</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">B88428F68E77C9AFF77EACBE81F511A9F5D99294</idno><idno type="DOI">10.1002/mds.870130224</idno><idno type="ArticleID">MDS870130224</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Calcium Channel Blockers (therapeutic use)</term><term>Calcium channel blockers</term><term>Humans</term><term>Hyperkinesis (drug therapy)</term><term>Hyperkinetic movement disorders</term><term>Male</term><term>Neurologic Examination (drug effects)</term><term>Tardive dyskinesia</term><term>Verapamil</term><term>Verapamil (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Calcium Channel Blockers</term><term>Verapamil</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hyperkinesis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Humans</term><term>Male</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium‐channel blockers for abnormal movements are discussed.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li><li>Illinois</li></region></list><tree><country name="États-Unis"><region name="Illinois"><name sortKey="Ovsiew" sort="Ovsiew" uniqKey="Ovsiew" last="Ovsiew">Ovsiew</name></region><name sortKey="Meador, Kimford J" sort="Meador, Kimford J" uniqKey="Meador K" first="Kimford J." last="Meador">Kimford J. Meador</name><name sortKey="Sethi, Kapil" sort="Sethi, Kapil" uniqKey="Sethi K" first="Kapil" last="Sethi">Kapil Sethi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E71 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E71 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B88428F68E77C9AFF77EACBE81F511A9F5D99294
|texte= Verapamil for severe hyperkinetic movement disorders
}}
| This area was generated with Dilib version V0.6.23. |  |